MLH1 and gastric cancer: As expected from sporadic gastric cancers with MSI, MLH1 down-regulation (fold change<0.5 as compared to a pool of mRNA from normal gastric tissues) characterized 70% of these tumors as compared to only 5% of the MSS tumors (Figure 1A).